IOVA logo

Iovance Biotherapeutics (IOVA)

Profile

Full Name

Iovance Biotherapeutics, Inc.

Ticker Symbol

IOVA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 15, 2010

Indexes

Not included

Website

http://www.iovance.com

Employees

838

Key Details

Price

$3.07(-4.95%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$164.07M(+13698.99% YoY)

Annual EPS

-$1.28(+32.28% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.07
IOVA price is $3.07

30-Day Relative Volume

0.87
IOVA 30-day relative volume is 0.87

Price Performance

Price Most recent change

-4.95%
IOVA price was down -4.95% on Apr 16, 2025

Price YTD change

-58.51%
IOVA price is down -58.51% since January 1st

Price 1-year change

-74.24%
IOVA price is down -74.24% year-on-year

Price 3-year change

-82.58%
IOVA price is down -82.58% over the past 3 years

Price Range

Price All-time high

$165.00
IOVA price is currently -98.14% below its historical high of $165.00

Price 3-year low

$2.70
IOVA price is currently +13.70% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.01B
IOVA market capitalization is $1.01 billion

Market cap 3-year change

-63.65%
IOVA market capitalization is down -63.65% over the past 3 years

Market cap All-time high

$7.72B
IOVA market capitalization is currently -86.97% below its historical high of $7.72 billion

Market cap sector rank

76.56%
IOVA market capitalization is higher than 76.56% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.2%
IOVA shares outstanding is up +17.2% year-on-year

Shares Outstanding 3-Year Change

+108.62%
IOVA shares outstanding is up +108.62% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.56
IOVA beta is 1.56

200-day SMA

$7.74
IOVA price is currently -60.32% below its 200-day simple moving average

50-day SMA

$4.16
IOVA price is currently -26.28% below its 50-day simple moving average

RSI

39.56
IOVA 14-day relative strength index is 39.56

Volume

0.87
IOVA 30-day relative volume is 0.87

ATR

$0.31
IOVA average true range is $0.31

10-day Historical Volatility

122.11%
IOVA 10-day historical volatility is 122.11%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$164.07M
IOVA annual revenue is $164.07 million

Revenue Analysts estimate

$452.92M
IOVA annual revenue is currently -63.78% lower than the consensus analysts' forecast

Revenue 1-year change

+13698.99%
IOVA annual revenue is up +13698.99% year-on-year

Revenue Sector rank

61.03%
IOVA annual revenue is higher than 61.03% of companies in Healthcare sector

EPS

EPS

-$1.28
IOVA annual earnings per share is -$1.28

EPS Analysts estimate

-$0.78
IOVA annual earnings per share is currently +64.50% higher than the consensus analysts' forecast

EPS 1-year change

+32.28%
IOVA annual earnings per share is up +32.28% year-on-year

EPS Sector rank

50.08%
IOVA annual earnings per share is higher than 50.08% of companies in Healthcare sector

Profit

Gross profit

$40.08M
IOVA annual gross profit is $40.08 million

Gross margin

24.43%
IOVA annual gross profit margin is 24.43%

Operating profit

-$395.28M
IOVA annual operating income is -$395.28 million

Operating margin

-240.92%
IOVA annual operating profit margin is -240.92%

Net income

-$372.18M
IOVA annual net profit is -$372.18 million

Net margin

-226.84%
IOVA annual net profit margin is -226.84%

Expenses

Total expenses

$559.35M
IOVA annual total expenses is $559.35 million

Operating expenses

$435.35M
IOVA annual total operating expenses is $435.35 million

Cost of goods sold

$124.00M
IOVA annual cost of goods sold is $124.00 million

Selling, general & administrative expenses

$153.02M
IOVA annual SGA is $153.02 million

Depreciation and amortization

$43.61M
IOVA annual depreciation & amortization is $43.61 million

Interest expense

-
IOVA annual interest expense value is unknown

Income tax

-$2.83M
IOVA annual income tax is -$2.83 million

EBIT & EBITDA

EBIT

-$395.28M
IOVA annual earnings before interest & taxes is -$395.28 million

EBITDA

-$351.67M
IOVA annual EBITDA is -$351.67 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$910.43M
IOVA annual total assets is $910.43 million

Non current assets

$453.41M
IOVA annual long term assets is $453.41 million

Current assets

$457.02M
IOVA annual total current assets is $457.02 million

Cash and cash equivalents

$115.69M
IOVA annual cash & cash equivalents is $115.69 million

Accounts receivable

$69.34M
IOVA annual accounts receivable is $69.34 million

Inventory

$51.52M
IOVA annual inventory is $51.52 million

Liabilities

Total liabilities

$200.02M
IOVA annual total liabilities is $200.02 million

Long term liabilities

$77.68M
IOVA annual total long term liabilities is $77.68 million

Current liabilities

$122.34M
IOVA annual total current liabilities is $122.34 million

Accounts payable

$27.51M
IOVA annual accounts payable is $27.51 million

Debt

Total debt

$58.26M
IOVA annual total debt is $58.26 million

Total debt 1-year change

-23.2%
IOVA annual total debt is down -23.2% year-on-year

Long term debt

$45.37M
IOVA annual long term debt is $45.37 million

Short term debt

$12.90M
IOVA annual short term debt is $12.90 million

Equity & Capital

Shareholders equity

$710.40M
IOVA annual stockholders equity is $710.40 million

Book value

$710.40M
IOVA annual book value is $710.40 million

Retained earnings

-$2.38B
IOVA annual retained earnings is -$2.38 billion

Working capital

$334.68M
IOVA annual working capital is $334.68 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$352.98M
IOVA annual cash flow from operations is -$352.98 million

Cash from operations 1-year change

+2.44%
IOVA annual cash flow from operations is up +2.44% year-on-year

Cash from investing

-$96.41M
IOVA annual cash flow from investing activities is -$96.41 million

Cash from investing 1-year change

+37.9%
IOVA annual cash flow from investing activities is up +37.9% year-on-year

Cash from financing

$390.66M
IOVA annual cash flow from financing activities is $390.66 million

Cash from financing 1-year change

-15.62%
IOVA annual cash flow from financing activities is down -15.62% year-on-year

CAPEX

CAPEX

$11.07M
IOVA annual capital expenditures is $11.07 million

CAPEX 1-year change

-50.34%
IOVA annual capital expenditures is down -50.34% year-on-year

Free Cash Flow

Free cash flow

-$364.05M
IOVA annual free cash flow is -$364.05 million

Free cash flow 1-year change

+5.22%
IOVA annual free cash flow is up +5.22% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

24.43%
IOVA annual gross profit margin is 24.43%

Operating margin

-240.92%
IOVA annual operating profit margin is -240.92%

Net margin

-226.84%
IOVA annual net profit margin is -226.84%

ROA & ROE

ROA

-44.02%
IOVA annual return on assets is -44.02%

ROE

-57.48%
IOVA annual return on equity is -57.48%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IOVA price to earnings ratio value is unknown

PE ratio Sector rank

-
IOVA price to earnings ratio is unknown

PB Ratio

PB ratio

1.42
IOVA price to book ratio is 1.42

PB ratio Sector rank

54.28%
IOVA price to book ratio is higher than 54.28% of companies in Healthcare sector

PS Ratio

PS ratio

6.14
IOVA price to sales ratio is 6.14

PS ratio Sector rank

70.64%
IOVA price to sales ratio is higher than 70.64% of companies in Healthcare sector

Enterprise value

Enterprise value

$949.15M
IOVA enterprise value is $949.15 million

Enterprise value Sector rank

75.31%
IOVA enterprise value is higher than 75.31% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.70
IOVA EV/EBITDA is -2.70

EV/EBITDA Sector rank

27.74%
IOVA EV/EBITDA is higher than 27.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.74
IOVA annual current ratio is 3.74

Quick ratio

3.31
IOVA annual quick ratio is 3.31

Leverage

Debt to equity

0.00
IOVA annual debt to equity ratio is 0.00

Interest coverage ratio

-
IOVA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

5
IOVA piotroski f-score is 5

Altman Z-Score

-1.46
IOVA altman z-score is -1.46

Analyst ratings

Recent major analysts updates

Apr 14, 25 Barclays
Overweight
Mar 3, 25 Truist Securities
Buy
Mar 3, 25 Goldman Sachs
Buy
Mar 3, 25 Chardan Capital
Buy
Feb 28, 25 Piper Sandler
Neutral
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 28, 25 Baird
Outperform
Jan 31, 25 Piper Sandler
Neutral
Nov 6, 24 HC Wainwright & Co.
Buy
Oct 24, 24 UBS
Buy

Institutional Ownership

Similar stocks

CDNA logo
CareDx (CDNA)
INMD logo
InMode (INMD)
NEOG logo
Neogen (NEOG)
NVAX logo
Novavax (NVAX)
HSTM logo
HealthStream (HSTM)
VRDN logo
Viridian Therapeutics (VRDN)
TXG logo
10x Genomics (TXG)
MDXG logo
MiMedx (MDXG)
USPH logo
US Physical Therapy (USPH)
  • What is the ticker symbol for Iovance Biotherapeutics?
  • Does Iovance Biotherapeutics pay dividends?
  • What sector is Iovance Biotherapeutics in?
  • What industry is Iovance Biotherapeutics in?
  • What country is Iovance Biotherapeutics based in?
  • When did Iovance Biotherapeutics go public?
  • Is Iovance Biotherapeutics in the S&P 500?
  • Is Iovance Biotherapeutics in the NASDAQ 100?
  • Is Iovance Biotherapeutics in the Dow Jones?
  • When was Iovance Biotherapeutics's last earnings report?
  • When does Iovance Biotherapeutics report earnings?
  • Should I buy Iovance Biotherapeutics stock now?

What is the ticker symbol for Iovance Biotherapeutics?

The ticker symbol for Iovance Biotherapeutics is NASDAQ:IOVA

Does Iovance Biotherapeutics pay dividends?

No, Iovance Biotherapeutics does not pay dividends

What sector is Iovance Biotherapeutics in?

Iovance Biotherapeutics is in the Healthcare sector

What industry is Iovance Biotherapeutics in?

Iovance Biotherapeutics is in the Biotechnology industry

What country is Iovance Biotherapeutics based in?

Iovance Biotherapeutics is headquartered in United States

When did Iovance Biotherapeutics go public?

Iovance Biotherapeutics's initial public offering (IPO) was on October 15, 2010

Is Iovance Biotherapeutics in the S&P 500?

No, Iovance Biotherapeutics is not included in the S&P 500 index

Is Iovance Biotherapeutics in the NASDAQ 100?

No, Iovance Biotherapeutics is not included in the NASDAQ 100 index

Is Iovance Biotherapeutics in the Dow Jones?

No, Iovance Biotherapeutics is not included in the Dow Jones index

When was Iovance Biotherapeutics's last earnings report?

Iovance Biotherapeutics's most recent earnings report was on Feb 27, 2025

When does Iovance Biotherapeutics report earnings?

The next expected earnings date for Iovance Biotherapeutics is May 9, 2025

Should I buy Iovance Biotherapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page